BioHealth News Archive

MaxBio Scientific Joins JHU Community – News – Johns Hopkins University Montgomery County Campus

MaxBio Scientific Joins JHU Community – News – Johns Hopkins University Montgomery County Campus

For Charles Li, locating his office at the Johns Hopkins University Montgomery County Campus is like coming home. Li received his MBA from the…

Read More
Cerecor Reports Encouraging Topline Data from a NIH Sponsored Proof-of-Concept Trial of CERC-501 in Treatment-Resistant Depression

Cerecor Reports Encouraging Topline Data from a NIH Sponsored Proof-of-Concept Trial of CERC-501 in Treatment-Resistant Depression

Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders,…

Read More
Jay Perman & Freeman Hrabowski: March for Science – Center Maryland Blog

Jay Perman & Freeman Hrabowski: March for Science – Center Maryland Blog

On Saturday, hundreds of thousands of people are expected to march in Washington, DC, to celebrate and defend science—at a time when many believe…

Read More
VLP Therapeutics Receives Notice of Allowance of Key U.S. composition of matter Patent for immune checkpoint PD-1/PD-L1/PD-L2 inserted alphavirus VLP – VLP Therapeutics

VLP Therapeutics Receives Notice of Allowance of Key U.S. composition of matter Patent for immune checkpoint PD-1/PD-L1/PD-L2 inserted alphavirus VLP – VLP Therapeutics

VLP Therapeutics, LLC. (“VLP”), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and antibody agents, today announced that…

Read More
Silver Spring-based United Therapeutics Corp. (NASDAQ: UTHR) partners with 3D Systems (NYSE: DDD) for human transplants – Washington Business Journal

Silver Spring-based United Therapeutics Corp. (NASDAQ: UTHR) partners with 3D Systems (NYSE: DDD) for human transplants – Washington Business Journal

Silver Spring-based United Therapeutics Corp. has been clear about its ambitions to build an unlimited supply of certain transplantable organs. Now, founder Martine Rothblatt…

Read More
Venture capital firms based in the Greater Washington, D.C. metro area are now competing with Silicon Valley-based venture capitalists to invest in D.C. companies – Washington Business Journal

Venture capital firms based in the Greater Washington, D.C. metro area are now competing with Silicon Valley-based venture capitalists to invest in D.C. companies – Washington Business Journal

The region has seen serious spikes in venture capital funding in the last decade — and more of our local firms are benefiting.  …

Read More
RegeneRx Licensee Receives FDA Permission to Conduct a Phase 3 Trial of RGN-137 for Epidermolysis Bullosa in U.S. – Feb 27, 2017

RegeneRx Licensee Receives FDA Permission to Conduct a Phase 3 Trial of RGN-137 for Epidermolysis Bullosa in U.S. – Feb 27, 2017

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that…

Read More
Careers Opportunities at Personal Genome Diagnostics

Careers Opportunities at Personal Genome Diagnostics

PGDx launched in 2010 to bring innovative genetic analyses to cancer researchers, physicians and patients. PGDx uses cutting-edge next-generation sequencing and analysis techniques to…

Read More
California’s $3-billion bet on stem cells faces final test : Nature News & Comment

California’s $3-billion bet on stem cells faces final test : Nature News & Comment

When California voters approved US$3 billion in funding for stem-cell research in 2004, biologists flocked to the state, and citizens dreamed of cures for Parkinson’s…

Read More
MedImmune goes after challenging lupus market – Medical Marketing and Media

MedImmune goes after challenging lupus market – Medical Marketing and Media

The lupus treatment landscape could soon welcome an entrant if a first-in-class anti-interferon monoclonal antibody (mAb) continues to hit clinical-trial targets. AstraZeneca and its…

Read More
Johns Hopkins Supporting Innovation With New Innovation Hub

Johns Hopkins Supporting Innovation With New Innovation Hub

The Johns Hopkins University announced today the opening of its state-of-the-art innovation hub, FastForward 1812. The 23,000-square-foot space near Johns Hopkins’ flagship hospital and…

Read More
Epigenomics AG: Blitz F16-83 GmbH to launch takeover offer for Epigenomics AG

Epigenomics AG: Blitz F16-83 GmbH to launch takeover offer for Epigenomics AG

Epigenomics AG (FSE: ECX; OTCQX: EPGNY) (“Epigenomics” or “Company”), Cathay Fortune International Company Limited (“CFIC”) and Blitz F16-83 GmbH (in the future Summit Hero Holding GmbH,…

Read More
AstraZeneca and MedImmune mark a key milestone with the ‘topping out’ of new global R&D centre in Cambridge, UK

AstraZeneca and MedImmune mark a key milestone with the ‘topping out’ of new global R&D centre in Cambridge, UK

AstraZeneca today marks a key milestone in its successful move to Cambridge, UK, with the ‘topping out’ of its new, state-of-the-art, strategic R&D centre…

Read More
BeneVir Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H and Other Platform Assets

BeneVir Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H and Other Platform Assets

BeneVir Biopharm, Inc., a biotechnology company developing oncolytic immunotherapies for the treatment of cancer, announced today that the U.S. Patent and Trademark Office has…

Read More
TEDCO and the Maryland Entrepreneurial Ecosystem – Survey

TEDCO and the Maryland Entrepreneurial Ecosystem – Survey

If you are part of the Maryland entrepreneurial community please take a few minutes to complete our survey. We are interested in the opinions…

Read More